Ultragenyx Financial Statements From 2010 to 2026

RARE Stock  USD 23.21  0.99  4.09%   
Ultragenyx's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Ultragenyx's valuation are provided below:
Gross Profit
-163.8 M
Profit Margin
(0.92)
Market Capitalization
2.3 B
Enterprise Value Revenue
2.827
Revenue
630.6 M
There are over one hundred nineteen available fundamental trend indicators for Ultragenyx, which can be analyzed over time and compared to other ratios. Investors should ensure to double-check all of Ultragenyx's current performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. As of January 8, 2026, Market Cap is expected to decline to about 2.4 B. In addition to that, Enterprise Value is expected to decline to about 2.3 B

Ultragenyx Total Revenue

676.48 Million

Check Ultragenyx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ultragenyx's main balance sheet or income statement drivers, such as Depreciation And Amortization of 42.9 M, Interest Expense of 76.1 M or Selling General Administrative of 388.3 M, as well as many indicators such as Price To Sales Ratio of 7.43, Dividend Yield of 0.0028 or PTB Ratio of 16.57. Ultragenyx financial statements analysis is a perfect complement when working with Ultragenyx Valuation or Volatility modules.
  
Build AI portfolio with Ultragenyx Stock
Check out the analysis of Ultragenyx Correlation against competitors.
For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.

Ultragenyx Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets913.5 M1.7 B840 M
Slightly volatile
Other Current Liabilities356.3 M339.4 M116 M
Slightly volatile
Total Current Liabilities415.6 M395.8 M142.9 M
Slightly volatile
Total Stockholder Equity466.8 M293.6 M394.8 M
Slightly volatile
Other Liabilities1.1 BB357.6 M
Slightly volatile
Property Plant And Equipment Net321.1 M305.8 M110.7 M
Slightly volatile
Accounts Payable46.8 M44.6 M17.4 M
Slightly volatile
Cash202.1 M199.8 M175.6 M
Slightly volatile
Non Current Assets Total828.7 M789.3 M338.5 M
Slightly volatile
Other Assets20.3 M19.4 M8.4 M
Slightly volatile
Cash And Short Term Investments519.3 M701.5 M461.2 M
Slightly volatile
Net Receivables147.1 M140.1 M38.3 M
Slightly volatile
Common Stock Total Equity44.1 K80.5 K44 K
Slightly volatile
Common Stock Shares Outstanding54.4 M104.1 M51.4 M
Slightly volatile
Liabilities And Stockholders Equity913.5 M1.7 B840 M
Slightly volatile
Non Current Liabilities Total1.1 BB363.3 M
Slightly volatile
Other Current Assets36 M46.3 M31.8 M
Slightly volatile
Other Stockholder Equity5.1 B4.8 BB
Slightly volatile
Total Liabilities1.5 B1.4 B506.2 M
Slightly volatile
Property Plant And Equipment Gross456.9 M435.2 M146 M
Slightly volatile
Total Current Assets588.6 M939.7 M531.2 M
Slightly volatile
Common Stock111.1 K105.8 K51.5 K
Slightly volatile
Property Plant Equipment313.6 M298.7 M103.2 M
Slightly volatile
Short Term Investments358.3 M501.7 M288.6 M
Slightly volatile
Net Tangible Assets161.7 M170.2 M326.8 M
Very volatile
Capital SurpluseB3.6 B1.7 B
Slightly volatile
Non Current Liabilities Other18.7 M19.6 M70.8 M
Pretty Stable
Current Deferred Revenue237.3 M226 M64.2 M
Slightly volatile
Net Invested Capital218.3 M229.8 M455.2 M
Very volatile
Net Working Capital649.3 M543.9 M429.7 M
Slightly volatile
Capital Stock76.8 K105.8 K63.5 K
Slightly volatile
Short and Long Term Debt Total32.3 M36.3 M37.9 M
Very volatile
Capital Lease Obligations32.3 M36.3 M37.9 M
Very volatile
Short Term Debt11.4 M11.8 M8.8 M
Slightly volatile

Ultragenyx Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization42.9 M40.9 M13.5 M
Slightly volatile
Selling General Administrative388.3 M369.9 M151.8 M
Slightly volatile
Other Operating Expenses1.3 B1.3 B519.2 M
Slightly volatile
Research Development842.7 M802.5 M346.1 M
Slightly volatile
Total Operating Expenses1.2 B1.2 B497.8 M
Slightly volatile
Interest Income44.1 M42 M13.1 M
Slightly volatile
Reconciled Depreciation42.9 M40.9 M15.5 M
Slightly volatile

Ultragenyx Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation190.8 M181.7 M76.3 M
Slightly volatile
Begin Period Cash Flow191 M252.3 M169.1 M
Slightly volatile
Other Cashflows From Financing Activities19.9 M21 M73.2 M
Pretty Stable
Depreciation42.9 M40.9 M13.5 M
Slightly volatile
Capital Expenditures8.2 M8.6 M22.7 M
Slightly volatile
Total Cash From Financing Activities318.8 M459.1 M285.5 M
Slightly volatile
End Period Cash Flow205.3 M211.8 M178.8 M
Slightly volatile
Sale Purchase Of Stock9.2 M9.7 M170.5 M
Slightly volatile
Issuance Of Capital Stock196.3 M342.9 M278.2 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio7.437.828.7 K
Slightly volatile
Dividend Yield0.00280.00310.0034
Slightly volatile
PTB Ratio16.5717.1619.7705
Slightly volatile
Days Sales Outstanding16191.26381
Slightly volatile
Book Value Per Share2.482.617.1366
Very volatile
Stock Based Compensation To Revenue0.310.32151
Slightly volatile
Capex To Depreciation0.230.244.0901
Slightly volatile
PB Ratio16.5717.1619.7705
Slightly volatile
EV To Sales8.869.338.2 K
Slightly volatile
Inventory Turnover1.611.530.5672
Slightly volatile
Days Of Inventory On Hand2342461.4 K
Slightly volatile
Payables Turnover4.462.282.9192
Very volatile
Sales General And Administrative To Revenue2.712.85205
Slightly volatile
Research And Ddevelopement To Revenue1.361.43574
Slightly volatile
Capex To Revenue0.01460.015431.6777
Slightly volatile
Cash Per Share6.756.067.7274
Slightly volatile
Days Payables Outstanding201212921
Pretty Stable
Income Quality0.890.840.8168
Very volatile
Intangibles To Total Assets0.20.170.2607
Slightly volatile
Current Ratio2.592.738.3327
Slightly volatile
Tangible Book Value Per Share0.370.395.4318
Very volatile
Receivables Turnover5.134.143.7709
Slightly volatile
Shareholders Equity Per Share2.412.547.1238
Very volatile
Debt To Equity3.373.210.6496
Slightly volatile
Capex Per Share0.07070.07450.348
Slightly volatile
Revenue Per Share5.855.572.4294
Slightly volatile
Interest Debt Per Share10.169.672.408
Slightly volatile
Debt To Assets0.570.540.1262
Slightly volatile
Operating Cycle321337130.7 K
Slightly volatile
Price Book Value Ratio16.5717.1619.7705
Slightly volatile
Days Of Payables Outstanding201212921
Pretty Stable
Ebt Per Ebit1.071.220.9949
Very volatile
Company Equity Multiplier5.575.32.4536
Slightly volatile
Long Term Debt To Capitalization0.420.690.3947
Slightly volatile
Total Debt To Capitalization0.740.70.1799
Slightly volatile
Debt Equity Ratio3.373.210.6496
Slightly volatile
Quick Ratio2.452.588.2727
Slightly volatile
Net Income Per E B T0.80.90.981
Slightly volatile
Cash Ratio0.550.584.2979
Slightly volatile
Days Of Inventory Outstanding2342461.4 K
Slightly volatile
Days Of Sales Outstanding16191.26381
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.890.921.0825
Very volatile
Price To Book Ratio16.5717.1619.7705
Slightly volatile
Fixed Asset Turnover1.181.90.968
Slightly volatile
Debt Ratio0.570.540.1262
Slightly volatile
Price Sales Ratio7.437.828.7 K
Slightly volatile
Asset Turnover0.350.340.1261
Slightly volatile
Price Fair Value16.5717.1619.7705
Slightly volatile

Ultragenyx Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.4 B3.2 B2.9 B
Slightly volatile
Enterprise Value2.3 BB2.7 B
Slightly volatile

Ultragenyx Fundamental Market Drivers

Ultragenyx Upcoming Events

15th of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
15th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Ultragenyx Financial Statements

Ultragenyx stakeholders use historical fundamental indicators, such as Ultragenyx's revenue or net income, to determine how well the company is positioned to perform in the future. Although Ultragenyx investors may analyze each financial statement separately, they are all interrelated. For example, changes in Ultragenyx's assets and liabilities are reflected in the revenues and expenses on Ultragenyx's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Ultragenyx. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue226 M237.3 M
Total Revenue644.3 M676.5 M
Cost Of Revenue88.2 M92.6 M
Stock Based Compensation To Revenue 0.32  0.31 
Sales General And Administrative To Revenue 2.85  2.71 
Research And Ddevelopement To Revenue 1.43  1.36 
Capex To Revenue 0.02  0.01 
Revenue Per Share 5.57  5.85 
Ebit Per Revenue(0.86)(0.90)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Ultragenyx is a strong investment it is important to analyze Ultragenyx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ultragenyx's future performance. For an informed investment choice regarding Ultragenyx Stock, refer to the following important reports:
Check out the analysis of Ultragenyx Correlation against competitors.
For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ultragenyx. If investors know Ultragenyx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ultragenyx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.37)
Revenue Per Share
6.463
Quarterly Revenue Growth
0.147
Return On Assets
(0.25)
Return On Equity
(3.13)
The market value of Ultragenyx is measured differently than its book value, which is the value of Ultragenyx that is recorded on the company's balance sheet. Investors also form their own opinion of Ultragenyx's value that differs from its market value or its book value, called intrinsic value, which is Ultragenyx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ultragenyx's market value can be influenced by many factors that don't directly affect Ultragenyx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ultragenyx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ultragenyx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ultragenyx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.